课题基金 / 基金详情

Translational Neuropsychopharmacology Research of Nicotine Addiction

Translational Neuropsychopharmacology Research of Nicotine Addiction
尼古丁成瘾的转化神经精神药理学研究
批准号:
10193286
负责人:
Brett Froeliger
金额:
$15.5万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-06-16 至 2021-07-31

项目摘要

项目成果

Brett Froeliger的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Nicotine addiction is a manifold process that involves dysregulated executive control, reward processing and negative affect. Preclinical models reveal that self-administration of nicotine produces an imbalance in corticostriatal glutamate transmission that mediates cue-induced reinstatement to nicotine seeking. Prior research suggests that N- acetylcysteine (NAC), a modified cysteine chain that regulates glial glutamate and normalizes cocaine-induced synaptic plasticity, may attenuate perceived smoking reward and smoking behavior. Crucially however, our preclinical data suggests NAC may be most effective under conditions of abstinence as a relapse prevention aid. Thus, pairing a smoking cessation medication (Varenicline: VRN) that promotes abstinence, with a relapse prevention aid (NAC), may produce greater cessation outcomes than either treatment alone. The overarching goal of this proposal is to use clinical and preclinical neuroscience to investigate limbic-striatal and corticostriatal circuits involved in nicotine addiction and determine the value of VRN+NAC for normalizing circuitry function and treating nicotine addiction. Smokers interested in quitting will be randomized to one of four placebo (PBO) controlled conditions to examine the individual and combined effects of VRN and NAC over 4-weeks. Following 1-week of treatment, participants will be contingently reinforced for 3 days of smoking abstinence and undergo an fMRI scan. Participants will be followed over the next 3-weeks of treatment and clinically relevant behaviors will be assessed. Relations between fMRI measures and clinical variable will be explored. In our analog preclinical studies that use the same treatment groups as the clinical studies, we will employ an optogenetic strategy to examine the efficacy of VRN+NAC at inhibiting synaptic plasticity in prelimbic (PL) and basolateral amygdala (BLA) inputs to the nucleus accumbens produced during cue-induced nicotine seeking.
期刊论文(4)
专著(0)
科研奖励(0)
会议论文
Mindfulness, Acceptance and Defusion Strategies in Smokers: a Systematic Review of Laboratory Studies.
吸烟者的正念、接受和解离策略:实验室研究的系统回顾。
DOI: 10.1007/s12671-017-0767-1
发表时间: 2018
期刊: Mindfulness
影响因子: 3.6
作者: [Serfaty,Shirley, Gale,Grace, Beadman,Matthew, Froeliger,Brett, Kamboj,SunjeevK]
通讯作者: Kamboj,SunjeevK
DOI: 10.3389/fpsyt.2018.00319
发表时间: 2018
期刊: Frontiers in psychiatry
影响因子: 4.7
作者: [Fridriksson JF, Rorden C, Newman-Norlund RD, Froeliger B, Thrasher JF]
通讯作者: Thrasher JF
Neural mechanisms mediating appetitive regulation and smoking in nicotine addiction
  • 批准号:
    10374104
  • 项目类别:
  • 资助金额:
    $44.14万
  • 财政年份:
    2020
  • 负责人:
    Brett Froeliger
  • 依托单位:
Neural mechanisms mediating appetitive regulation and smoking in nicotine addiction
  • 批准号:
    10596991
  • 项目类别:
  • 资助金额:
    $39.23万
  • 财政年份:
    2020
  • 负责人:
    Brett Froeliger
  • 依托单位:
Examining the effects of Theta Burst Stimulation on corticothalamic mediated inhibitory control and smoking relapse vulnerability
  • 批准号:
    10245990
  • 项目类别:
  • 资助金额:
    $32.0万
  • 财政年份:
    2020
  • 负责人:
    Brett Froeliger
  • 依托单位:
Translational Neuropsychopharmacology Research of Nicotine Addiction
海外基金